COVID-19 mRNA vaccine (BNT162) Date of First Authorisation/Renewal of the Authorisation - Form to be diluted 30 µg/dose for adults and ≥12 years (purple cap)

Medical Information

In order to provide you with relevant and meaningful content we need to know more about you.

Please choose the category that best describes you.

This content is intended for U.S. Healthcare Professionals. Would you like to proceed?

Date of first authorisation: 21 December 2020

Date of latest renewal: 03 November 2021